My watch list
my.bionity.com  
Login  

1,838 Newest Publications of Future Medicine

rss

GenoType® MTBDRplus compared with conventional drug-susceptibility testing of Mycobacterium tuberculosis in a low-resistance locale

31-03-2011 | Zoe Gitti; Elpis Mantadakis; Sofia Maraki; George Samonis, Future Microbiology, 2011

Aim: To determine the diagnostic accuracy of Geno Type® MTBDRplus compared with conventional proportional method (PM) drug susceptibility testing (DST) for detecting drug resistance of Mycobacterium tuberculosis (MTB) clinical isolates derived from the University Hospital of Heraklion, Crete, ...

more

Redefining cerebral malaria by including malaria retinopathy

31-03-2011 | Nicholas AV Beare; Susan Lewallen; Terrie E Taylor; Malcolm E Molyneux, Future Microbiology, 2011

Accurate diagnosis of cerebral malaria (CM) is important for patient management, epidemiological and end point surveillance, and enrolling patients with CM in studies of pathogenesis or therapeutic trials. In malaria-endemic areas, where asymptomatic Plasmodium falciparum parasitemia is ...

more

Azole resistance in Aspergillus fumigatus: a new challenge in the management of invasive aspergillosis?

31-03-2011 | Eveline Snelders; Willem JG Melchers; Paul E Verweij, Future Microbiology, 2011

Azole resistance is emerging in Aspergillus fumigatus isolates. The exact mechanism of evolution of azole resistance has not been fully elucidated yet but increasing evidence indicates a role for azole fungicide used in agriculture. Patients confronted with an invasive fungal infection from ...

more

Epidemiology and genetics of VIM-type metallo-β-lactamases in Gram-negative bacilli

31-03-2011 | Wei-Hua Zhao; Zhi-Qing Hu, Future Microbiology, 2011

Metallo-β-lactamases (MBLs) are a rapidly evolving group of β-lactamases, which hydrolyze most β-lactams including the carbapenems. Of the known MBLs, VIMs are one of the most common families, with 27 variants detected in at least 23 species of Gram-negative bacilli from more than 40 ...

more

Clinical significance of HIV reverse-transcriptase inhibitor-resistance mutations

31-03-2011 | Shiro Ibe; Wataru Sugiura, Future Microbiology, 2011

In this article, we summarize recent knowledge on drug-resistance mutations within HIV reverse transcriptase (RT). Several large-scale HIV-1 genotypic analyses have revealed that the most prevalent nucleos(t)ide analog RT inhibitor (NRTI)-resistance mutation is M184V/I followed by a series of ...

more

Immunotherapeutic potential of neutralizing antibodies targeting conserved regions of the HCV envelope glycoprotein E2

31-03-2011 | Allan GN Angus; Arvind H Patel, Future Microbiology, 2011

HCV is a major cause of chronic liver disease worldwide. There is no vaccine available and the current antiviral therapies fail to cure approximately half of treated patients. Liver disease caused by HCV infection is the most common indication for orthotopic liver transplantation. ...

more

Mosquito RNAi is the major innate immune pathway controlling arbovirus infection and transmission

31-03-2011 | Carol D Blair, Future Microbiology, 2011

Mosquito-borne arboviruses cause serious diseases in humans that are increasingly becoming public health problems, yet arbovirus infections cause minimal pathology in the mosquito vector, allowing persistent infections and lifelong virus transmission. The principal mosquito innate immune ...

more

VIth World Melioidosis Congress report: celebrating a century of research

31-03-2011 | Tim Inglis, Future Microbiology, 2011

Future Microbiology , March 2011, Vol. 6, No. 3, Pages 263-264.

more

Bulletin Board

31-03-2011 | Future Microbiology, 2011

Future Microbiology , March 2011, Vol. 6, No. 3, Pages 259-261.

more

Virulence of Entamoeba histolytica: a challenge for human health research

31-03-2011 | Fernando Anaya-Velázquez; Felipe Padilla-Vaca, Future Microbiology, 2011

Future Microbiology , March 2011, Vol. 6, No. 3, Pages 255-258.

more

Page 120 From 184
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE